Insights
Practical notes on the platform, security, and where AI in regulated life sciences is heading. No filler, no fluff.
Thought leadership · Strategy
Knowledge in R&D leaves when people do. Altio builds the longitudinal record that survives them, and a decision intelligence layer that answers questions across every module it runs.
Platform · Architecture
Our patent-pending core encodes what a domain requires once, then extends it, so every new domain inherits the same traceable record instead of a rebuild.
Platform · Architecture
Traceability is not a feature bolted on after the fact. At TRL 4, we can show the working, not just the output, because the architecture was built for it from the start.
Platform · Security
Access control, encryption, and threat modeling built from first principles, an embedded-systems approach applied to a platform that cannot afford to get this wrong.
Thought leadership · Regulatory
Every regulated decision stays with a qualified human expert. That is why Altio's risk profile is minimal/limited risk, not classified as high-risk under the EU AI Act.
Thought leadership · Strategy
Most point tools get rebuilt for every new domain. COG is built once at the core and extended instead, and that is the bet we are making.
Platform · Security
AI agents do the discovery and drafting, deterministic code does the deciding, and every gate between them fails closed.